0.5 Hours
This session will introduce issues related to assessing people's end of life care needs through a proxy when the individual is not able to communicate directly with the person carrying out the assessment.
0.5 Hours
With the advent of organ transplantation, patients suffering from end-stage organ failure no longer face inevitable death or a lifetime of complex medical care and those receiving a transplanted organ can often return to a normal lifestyle. As a result of this success, coupled with an ageing population, there are increasing numb....
0.5 Hours
This session will describe what is meant by the terms palliative care and end of life care, and what they have in common. Two case studies will be used to explain their relevance to patients with advanced progressive illnesses, and their families. The session will provide an overview of key components of palliative care and end....
0.5 Hours
Psychological assessment is one of the four core areas (also known as domains) of a holistic assessment. In this session you will explore this domain and its potential interactions with the other areas. This session was reviewed by Carolyn Doyle and Christina Faull and last updated in November 2015.
0.5 Hours
This session will describe how pain in the intensive care unit (ICU) is multi-factorial and difficult to assess. It will show how potentially useful drugs may also have adverse effects and how non-pharmacological treatment effects must be maximized. The session will also review effects of pain and describe how analgesia use....
0.5 Hours
This review does not attempt to be exhaustive but deals with some of the more common viral illnesses that can necessitate ICU admission. Despite this, there remain notable exclusions including arboviruses (including those which cause viral haemorrhagic fever), zoonotic viruses (including rabies), and the hepatitis viruses, which....
0.5 Hours
Pulmonary oedema is the accumulation of fluid within the interstitium and air spaces of the lung. It may form due to intrinsic lung pathology or systemic dysfunction.
0.5 Hours
This session will provide an overview of pharmacokinetic (PK) maturation during infancy and the use of size models to describe PK differences between children and adults. It will go on to describe known pharmacodynamic (PD) differences and consider the impact of pharmacogenomic (PG) differences in infancy.
0.5 Hours
Barrie Phypers and JM Tom Pierce give an in-depth overview of lactate physiology in health and disease
0.5 Hours
This session will cover the techniques for managing the airway in the severely-injured patient.
0.5 Hours
This session describes the surface anatomy, boundaries and superficial/deep structures in the antecubital fossa. It describes the variations in venous and arterial vasculature in the region and clinical importance to the anaesthetist of this fossa.
0.5 Hours
This session describes the anatomy of the oral cavity, pharynx and larynx. The nerve supply to the larynx and the implications of damage to these nerves is also described.
0.5 Hours
This session describes the anatomy of the upper and lower limbs, concentrating on the bones and joints. Particular attention is paid to those bones and joints that are of importance to the anaesthetist.
0.5 Hours
This session describes the determinants of systemic blood pressure, including physical, neurological, vasomotor and hormonal regulation, and the role of the kidney in blood pressure control.
0.5 Hours
This session describes the structure, function and mechanism of action of enzymes. Their role in regulation and cellular physiology is identified.
0.5 Hours
In this session you will gain an understanding of the fluid compartments and the factors involved in the distribution of fluid between them. This is a vital skill which will enable you to adequately assess and treat sick patients and help you to choose which fluid to give. It will also help to guide your prescription of fluid in....
0.5 Hours
This session explains the variations in pharmacokinetics as observed in different anaesthetic patient populations.
0.5 Hours
This session will discuss clearance and volume of distribution and methods used to estimate and measure these kinetic parameters.
0.5 Hours
This session describes the different types of antiplatelet drugs, their specific benefits and the contraindications for their use.
0.5 Hours
This session covers the induction agent etomidate. Etomidate (in clinical use since 1972) has a very stable haemodynamic profile. However, due to the inhibition of adrenocortical steroid synthesis after a single dose or infusion, the popularity of etomidate has declined.
0.5 Hours
This session will describe the signs and symptoms of anaphylaxis and some common causative agents will be considered. The pathophysiology and epidemiology of anaphylaxis will also be discussed.
0.5 Hours
This session reviews the relationship between population and sample, and introduces the concept of point estimation. The uncertainty about any estimated value is discussed with reference to making clinical decisions based on summary values identified in clinical trials and the single sample t-test is introduced.
0.5 Hours
This session covers the aetiology, natural history, predisposing factors, clinical presentation and management of recurrent bacterial vaginosis, candidiasis, and trichomoniasis infection in women.
0.5 Hours
Evidence-based medicine (EBM) promotes the concept that one should apply the best evidence from medical research, particularly that derived from randomized controlled trials (RCT), to the treatment of patients. The aim is not to exclude, but to add to the methods associated with traditional clinical practice: clinical experience....